Marco Amadio

About Marco Amadio

This author has not yet filled in any details.
So far Marco Amadio has created 75 blog entries.

25 10, 2019

Diatech at the TSCO (Thai Society of Clinical Oncology) Annual Meeting 2019
Diatech at the TSCO (Thai Society of Clinical Oncology) Annual Meeting 2019

News

Diatech at the TSCO (Thai Society of Clinical Oncology) Annual Meeting 2019

Marco Amadio 2019-10-25T11:30:02+00:00

Read More

12 09, 2019

Meet Diatech at Medica 2019!
Meet Diatech at Medica 2019!

News

Meet Diatech at Medica 2019!

Marco Amadio 2019-09-16T16:57:31+00:00

Read More

12 09, 2019

Request an appointment for Medica 2019!
Request an appointment for Medica 2019!

Events

Request an appointment for Medica 2019!

Marco Amadio 2019-09-16T16:58:12+00:00

Read More

1 08, 2019

Sara Ricci et. al, Genotyping of Pestivirus A (Bovine Viral Diarrhea Virus 1) detected in faeces and in other specimens of domestic and wild ruminants at the wildlife-livestock interface

Marco Amadio 2019-08-01T09:33:17+00:00

Read More

31 07, 2019

Sergio Migliore et. al, Large-scale PRNP genotyping of small ruminants using an automated high-throughput MALDI-TOF MS assay.

Marco Amadio 2019-07-31T09:07:37+00:00

Read More

17 06, 2019

Riccardo Bernasconi et. al, Extra-axial anaplastic astroblastoma in a 67 year old woman

Marco Amadio 2019-07-02T09:59:27+00:00

Read More

11 06, 2019

Ilaria Francaviglia et. al, Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients

Marco Amadio 2019-06-11T09:44:31+00:00

Read More

26 05, 2019

Libor Stanek et. al, Expression level of NRP1 and SMAD2 in correlation to mutational status of RAS (BRAF) in pancreatic cancer.

Marco Amadio 2019-06-05T14:12:41+00:00

Read More

6 05, 2019

Vincenzo De Falco et. al, A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant.

Marco Amadio 2019-06-05T12:52:50+00:00

Read More

2 05, 2019

Paola Bordi et. al, From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC

Marco Amadio 2019-05-02T09:45:38+00:00

Read More

1 2 3 Next